Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Open-Label, Multiple-Dose, Single-Arm Exposure Study of Maxigesic® IV in Patients With Acute Pain Following Orthopedic, General or Plastic Surgery

NCT04005755 is registered in ClinicalTrials.gov with AFT Pharmaceuticals, Ltd. as lead sponsor.

NCT NCT04005755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Open-Label, Multiple-Dose, Single-Arm Exposure Study of Maxigesic® IV in Patients With Acute Pain Following Orthopedic, General or Plastic Surgery
Lead sponsor
AFT Pharmaceuticals, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
July 22, 2019
Completion date
July 7, 2020
Enrollment
232 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain